x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

46:39

The Indiana boy driving CGT development

Molecule to Market: Inside the outsourcing space ·

2026/04/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sean Werner, Chief Technology Officer at BioLife Solutions,Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sean, covering: The value of learning your craft in big pharma, and the steep transition from technical expert to President of a spinout Why BioLife moved from board involvement to acquiring Sean’s company outright The critical

en

46:23

DCAT Live - Morgan Stanley CDMO CEO Dinner

Molecule to Market: Inside the outsourcing space ·

2026/04/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alessandro Maselli, President and Chief Executive Officer at Catalent and Franco Negron is the Chief Executive Officer at Simtra BioPharma Solutions.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology ecosystem with his esteemed guests during a live fireside chat at the DCAT Morgan Stanley CDMO CEO Dinner. Alessandro Maselli is the President and Chief

en

52:25

DCAT Live Panel - Stick or Twist with Capacity in...

Molecule to Market: Inside the outsourcing space ·

2026/03/30

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:Jake Behrman, 3i Dirk Lange, Pyramid Pharma Hanns-Christian Mahler, ten23 J.D. Mowery, AST/Engage Sarah Stevens, Chrysalis Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology ecosystem with his guests live from DCAT 2026. The event was hosted by Lead Candidate and sponsored by 3i private equity... and Molecule to Market, Molecule to Market is also

en

57:23

From consulting stay at home dad to global CRO CEO

Molecule to Market: Inside the outsourcing space ·

2026/03/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Greg Plunkett, Founder and CEO of Accelagen.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Greg, covering: How years at big pharma exposed him to the full journey from concept to commercialisation. Why stepping into a smaller organisation gave him the practical tools and confidence to start his own venture. How following market signals

en

52:44

From big pharma manufacturing lead to CDMO CEO

Molecule to Market: Inside the outsourcing space ·

2026/03/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Joerg Ahlgrimm, CEO SK pharmteco.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Joerg, covering: His journey from East Germany to leading global manufacturing organisations. How building and integrating acquired CDMO relationships ultimately led him to Lonza, where he helped scale the manufacturing network from fifteen to thirty

en

26:11

M2M Pulse: 7 Trends CDMO You Can’t Ignore

Molecule to Market: Inside the outsourcing space ·

2026/03/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO and C-suite leaders from the CDMO ecosystem, exploring the overlooked trends for 2026.Nick Fortin, CEO, Codis Ankit Gupta, CEO, InstaPill Eric Edwards, MD, PhD, CEO, Phlow USA Dirk T. Lange, CEO, Pyramid Pharma Services Kaan-Fabian Kekec, Partner, Simon-Kucher Healthcare and Life Sciences J.D. Mowery, President, CDMO Division, Bora Pharmaceuticals Matthew Bio, CSO,

en

48:58

25+ years & 200+ deals - meet the prolific pharma...

Molecule to Market: Inside the outsourcing space ·

2026/02/27

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Banks Bourne, Founder & Chief Executive Officer at Bourne Partners.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Banks, covering: How making a bet in the right place at the right time sparked an extraordinary journey in pharma investing. The founding of Bourne Partners and a twenty five plus year ride through multiple market

en

45:45

The 30-year, overnight success

Molecule to Market: Inside the outsourcing space ·

2026/02/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Julian Casciano, President & CEO at eMAX Health.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Julian, covering: How a family tragedy led him into the healthcare and pharmaceutical world. Why corporate life was not for him, but the valuable lessons he learned during his time at KPMG. The turbulent journey with a venture capital

en

33:44

The CDMO CEO Operator Playbook for 2026

Molecule to Market: Inside the outsourcing space ·

2026/02/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO and C-suite leaders from the CDMO ecosystem, exploring two simple questions that reveal what’s really happening inside the building:What’s the biggest internal business challenge for the year ahead? And what’s the biggest opportunity inside their business in 2026? Your host, Raman Sehgal, brings together a punchy set of operator insights spanning commercial readiness,

en

55:16

The AI CEO changing pharma from the inside

Molecule to Market: Inside the outsourcing space ·

2026/02/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Pep Gubau, CEO, CTO & Co-Founder at Aizon.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Pep, covering: How working out what not to do very early on led to two successful growth and exit stories. Why surrounding yourself with smarter people is essential to learning, scaling, and long term success. How the industry’s underuse of

en

29:12

CDMO & C-suite headwinds for 2026

Molecule to Market: Inside the outsourcing space ·

2026/01/30

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO/c-suite leaders from the CDMO space, who discuss the big headwinds for the pharmaceutical and biotechnology space for 2026.Show features: Christiane Bardroff, Chief Operating Officer (COO) at Rentschler Biopharma SE Philip Macnabb, Chief Executive Officer at Curia Kaan-Fabian Kekec, Partner at Simon-Kucher‘s Healthcare & Life Sciences division Dirk T. Lange , Chief

en

48:50

Insights from JPM

Molecule to Market: Inside the outsourcing space ·

2026/01/23

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with three senior leaders that attended The JPM's Annual Healthcare Conference 2026:Chris Garabedian, CEO, Xontogeny and Portfolio Manager, PXV Fund Dean McAlister, Executive Vice President, Inizio Biotech Catherine Hunter, Head of Business Development at ramarketing Hear from experts who have seen multiple cycles and know the difference between noise and signal.We talk real

en

32:28

CDMO C-suite optimism pulse for 2026

Molecule to Market: Inside the outsourcing space ·

2026/01/16

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO/c-suite leaders from the CDMO space, who discuss the optimism levels for the pharmaceutical and biotechnology space for 2026.Guests include: Christiane Bardroff, Chief Operating Officer (COO) at Rentschler Biopharma SE Philip Macnabb, Chief Executive Officer at Curia Kaan-Fabian Kekec, Partner at Simon-Kucher‘s Healthcare & Life Sciences division Dirk T. Lange ,

en

53:06

The AI entrepreneur fighting against cancer

Molecule to Market: Inside the outsourcing space ·

2026/01/09

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Selin Kurnaz, Co-Founder and CEO at Massive Bio,Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Selin, covering: How a cancer diagnosis in her family led Selin down a path of accidental entrepreneurship, fundraising, and the application of AI in drug development. The major pivots in Massive Bio’s journey that transformed it into a

en

45:51

25+ years as pharma-focused PE fund

Molecule to Market: Inside the outsourcing space ·

2026/01/02

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jim Gale, Founding Partner & Managing Director at Signet.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jim, covering: The origins of growth equity in private equity and how it led to the founding of Signet, a fund built on deep domain expertise. Why private equity is a growing asset category but still remains undervalued and

en

32:44

2025 Unwrapped: Top 5 Episodes

Molecule to Market: Inside the outsourcing space ·

2025/12/26

As we draw close to the end of 2025, our host Raman Sehgal talks about the top 5 episodes of the year.Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

en

56:52

Doctor Entrepreneur who pulled off a $1.4b exit

Molecule to Market: Inside the outsourcing space ·

2025/12/19

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Thomas Dobmeyer, medical, entrepreneur and investor at ekwithree.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Thomas, covering: Choosing to freelance and consult as a medic after qualifying in medicine. Co-founding a niche regulatory affairs firm and growing it into a 3,000-person multinational pharmaceutical solutions

en

25:06

M2M Monitor Special - 2026

Molecule to Market: Inside the outsourcing space ·

2025/12/12

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with our host Raman Sehgal. Raman distils dozens of executive conversations across 2025 into three key insights you can take into 2026 for you and your organization. Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the

en

49:58

The master building CEO leading Codis

Molecule to Market: Inside the outsourcing space ·

2025/12/05

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Nick Fortin, Chief Executive Officer at Codis.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Nick, covering: Nick’s desire to scratch that entrepreneurial itch, while recognising he was missing a key tool in his toolbox, which led him to pursue a midlife MBA. His turnaround role at Neopharma exposed him to major players in the pharma

en

49:47

From R&D to CRO CEO

Molecule to Market: Inside the outsourcing space ·

2025/11/28

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dr. Fozia Saleem, Chief Executive Officer at Magnitude Biosciences.Your host, Raman Sehgal, speaks with Fozia about the pharmaceutical and biotechnology supply chain, including: How her early roles shaped her focus on applying science and innovation in a practical way The contrast between working in tobacco and vape R&D and traditional pharma research How a post-COVID

en

268 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter